136 related articles for article (PubMed ID: 30324116)
21. Characterization of pilQ, a new gene required for the biogenesis of type 4 fimbriae in Pseudomonas aeruginosa.
Martin PR; Hobbs M; Free PD; Jeske Y; Mattick JS
Mol Microbiol; 1993 Aug; 9(4):857-68. PubMed ID: 7901733
[TBL] [Abstract][Full Text] [Related]
22. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
[TBL] [Abstract][Full Text] [Related]
23. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
[TBL] [Abstract][Full Text] [Related]
24. Single-residue changes in the C-terminal disulfide-bonded loop of the Pseudomonas aeruginosa type IV pilin influence pilus assembly and twitching motility.
Harvey H; Habash M; Aidoo F; Burrows LL
J Bacteriol; 2009 Nov; 191(21):6513-24. PubMed ID: 19717595
[TBL] [Abstract][Full Text] [Related]
25. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
26. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
[TBL] [Abstract][Full Text] [Related]
27. Immunization with Bivalent Flagellin Protects Mice against Fatal
Behrouz B; Hashemi FB; Fatemi MJ; Naghavi S; Irajian G; Halabian R; Imani Fooladi AA
J Immunol Res; 2017; 2017():5689709. PubMed ID: 29201922
[No Abstract] [Full Text] [Related]
28. Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.
Sen-Kilic E; Blackwood CB; Huckaby AB; Horspool AM; Weaver KL; Malkowski AC; Witt WT; Bevere JR; Damron FH; Barbier M
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199354
[No Abstract] [Full Text] [Related]
29. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
Priebe GP; Brinig MM; Hatano K; Grout M; Coleman FT; Pier GB; Goldberg JB
Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239
[TBL] [Abstract][Full Text] [Related]
30. The Pseudomonas aeruginosa PilSR Two-Component System Regulates Both Twitching and Swimming Motilities.
Kilmury SLN; Burrows LL
mBio; 2018 Jul; 9(4):. PubMed ID: 30042200
[TBL] [Abstract][Full Text] [Related]
31. The effect of in silico targeting Pseudomonas aeruginosa patatin-like protein D, for immunogenic administration.
Chirani AS; Majidzadeh R; Pouriran R; Heidary M; Nasiri MJ; Gholami M; Goudarzi M; Omrani VF
Comput Biol Chem; 2018 Jun; 74():12-19. PubMed ID: 29524839
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 2 represses nonpilus adhesin-induced signaling in acute infections with the Pseudomonas aeruginosa pilA mutant.
Lorenz E; Chemotti DC; Vandal K; Tessier PA
Infect Immun; 2004 Aug; 72(8):4561-9. PubMed ID: 15271916
[TBL] [Abstract][Full Text] [Related]
33. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
[TBL] [Abstract][Full Text] [Related]
34. Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against
Fakoor MH; Mousavi Gargari SL; Owlia P; Sabokbar A
Infect Drug Resist; 2020; 13():1651-1661. PubMed ID: 32606816
[TBL] [Abstract][Full Text] [Related]
35. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization and Functional Analysis of the PilQ
Faezi S; Nikokar I; Elmi A; Ghasemi Y; Farahbakhsh M; Salimi Chirani A; Mahdavi M
Avicenna J Med Biotechnol; 2018; 10(1):34-40. PubMed ID: 29296265
[TBL] [Abstract][Full Text] [Related]
37. Type IV pilus protein PilA of Pseudomonas aeruginosa modulates calcium signaling through binding the calcium-modulating cyclophilin ligand.
Okuda J; Hayashi N; Arakawa M; Minagawa S; Gotoh N
J Infect Chemother; 2013 Aug; 19(4):653-64. PubMed ID: 23266901
[TBL] [Abstract][Full Text] [Related]
38. Type IV pilus genes pilA and pilC of Pseudomonas stutzeri are required for natural genetic transformation, and pilA can be replaced by corresponding genes from nontransformable species.
Graupner S; Frey V; Hashemi R; Lorenz MG; Brandes G; Wackernagel W
J Bacteriol; 2000 Apr; 182(8):2184-90. PubMed ID: 10735861
[TBL] [Abstract][Full Text] [Related]
39. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
[TBL] [Abstract][Full Text] [Related]
40. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
Baker SM; Pociask D; Clements JD; McLachlan JB; Morici LA
Vaccine; 2019 Feb; 37(6):808-816. PubMed ID: 30638799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
